Richard Lehman’s journal review—24 February 2014

NEJM  20 Feb 2014  Vol 370 699   This week, the NEJM is big on bevacizumab. Amongst the crowd of mabs, this is one of the best known: Avastin is a humanized monoclonal antibody directed against vascular endothelial growth factor-A which has been on the market since 2004. It has had its ups and downs, and […]

Read More…

Giridhara R Babu: Health for Indians—who cares about it anyway?

Political parties often pitch intensively against a few individuals for maximum media bites. There is, however, no real discussion of the issues which affect the lives of scores of Indians. “Development” has recently become the buzzword of political parties. If development means economic and social transformation, then health should be seen as an essential component. Our country’s future will […]

Read More…

Richard Hurley: We need your help: what will India’s 2014 general elections mean for health?

In a couple of months India will hold parliamentary elections to determine its next central government. This administration, due to hold office from June, will also have responsibility for drafting India’s 13th five year plan, which is key to its direction of development from 2017. Prime Minister Manmohan Singh has said that he will not […]

Read More…

Manica Balasegaram: Drugs for the poor, drugs for the rich—why the current research and development model doesn’t deliver

The past month has seen the reputation of “Big Pharma” dented more than usual. The CEO of German pharmaceutical company Bayer, Marijn Dekkers, was reported as saying that the company didn’t develop a cancer drug for the Indian market, but rather “for Western patients who can afford it.” The comment summed up the attitude of […]

Read More…

Anita Jain: Training science communicators in India

“Acupuncture boosts libido,” blared the headline of a leading Indian daily. “Acupuncture effective treatment for breast cancer,” proclaimed another. These are in effect reporting a study which examined if acupuncture is any better than drugs in treating hot flashes in breast cancer patients on anti-estrogen therapy, and found no difference. The study participants included 50 […]

Read More…

Vijayaprasad Gopichandran: The doctor-patient relationship—from blind faith to strategic trust

The relationship between a physician and their patient is a sacred covenant which is fundamental to successful clinical outcomes. From Hippocratic times when there was a strong tinge of altruism associated with the practice of medicine, to the more recent provider-client model of healthcare, one thing that has remained constant has been an undercurrent of trust. […]

Read More…